Skip to main content
. Author manuscript; available in PMC: 2020 Dec 14.
Published in final edited form as: Exp Neurol. 2020 Apr 11;329:113309. doi: 10.1016/j.expneurol.2020.113309

Table 1.

Partial list of CNS diseases characterized by mitochondrial dysfunction and evidence of pharmacological induction of MB as therapeutic interventions for each.

Disease Mitochondrial Dysfunction Tested MB Treatments References
Acute Diseases
Traumatic Brain Injury Ischemia: ↓OXPHOS proteins, ↓ATP synthesis, ↓ATP-dependent cellular processes, ↓ion homeostasis Reperfusion: ↑ROS, ↑oxidative stress, ↑Ca2+, mPTP opening, ↑cell death Quercetin: ↑PGC-1α, ↓cell death
DEX: ↑PGC-1α, ↓cell death, ↑behavior
7,8-DHF: ↑PGC-1α, ↑function
SS-31: ↑PGC-1α, ↑function, ↑behavior
(Li et al., 2018c)
(Li et al., 2018a)
(Krishna et al., 2017)
(Zhu et al., 2018)
Spinal Cord Injury Formoterol: ↑PGC-1α, ↓cell death, ↑function
LY344864: ↑PGC-1α, ↓cell death, ↑function
Mitochondrial transplant: ↑pAKT, ↑function, ↓cell death
(Scholpa et al., 2019a; Scholpa et al., 2019b)
(Simmons et al., 2019)
(Li et al., 2019)
Stroke Mitochondrial transplant: ↑pAKT, ↓cell death, ↑function
Daidzein: ↓cell death, antioxidant
Metformin: ↓cell death, ↑behavior
Melatonin: ↑mitophagy, antioxidant
(Chang et al., 2019)
(Hayakawa et al., 2016)
(Cao et al., 2017)
(Andrzejewski et al., 2014; Owen et al., 2000)
(Qi et al., 2017)
Neurodegenerative
Alzheimer’s Disease ↓MB, ↑mitochondrial size and structural damage, ↓content, ↑fragmentation, ↑mtDNA mutations TZDs: ↑behavior
Resveratrol: ↑PGC-1α, ↑behavior, ↑pAKT
AICAR: ↑behavior, ↑pAKT
Melatonin: ↑PGC-1α, ↑function, ↓Aβ
(Cheng et al., 2016; Heneka et al., 2015; Risner et al., 2006; Watson et al., 2005)
(Vingtdeux et al., 2010)
(Wang et al., 2019)
Parkinson’s Disease ↑mtDNA mutations (complex I), ↑oxidative damage, ↓PGC-1α, ↓OXPHOS, ↓homeostasis Bezafibrate: ↑PGC-1α, ↑behavior Resveratrol: ↑PGC-1α, ↑function, ↓cell death
LY344864: ↑PGC-1α, ↑function, ↓cell death
Triterpenoids: ↑Nrf2, antioxidant
(Tufekci et al., 2011)
(Corona and Duchen, 2016)
(Peng et al., 2016)
(Scholpa et al., 2018a)

Adaption from (Gibbs et al., 2018c). Arrows indicated increase (↑) and decrease (↓). AICAR: 5-aminoimidazole-4-carboxamide ribonucleotide, ATP: adenosine triphosphate, Ca2+: calcium ion, DEX: dexmedetomidine, ETC: electron transport chain, MB: mitochondrial biogenesis, mPTP: membrane permeability transition pore, mtDNA: mitochondrial DNA, PGC-1α: peroxisome proliferator-activated receptor-γ coactivator 1-α, OXPHOS: oxidative phosphorylation, ROS: reactive oxygen species, TFAM: mitochondrial transcription factor A, TZDs: thiazolidinediones, 7,8-DHF: dihydroxyflavone.